captopril has been researched along with Ventricular Fibrillation in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (23.53) | 18.7374 |
| 1990's | 8 (47.06) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 1 (5.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y; Ristagno, G; Sun, S; Tang, W; Wang, H; Wang, T; Weil, MH | 1 |
| Chen, JB; Huang, CX; Sun, XM | 1 |
| Chai, LM; Lou, LX; Lü, XY; Wang, SR; Wu, AM; Zhai, JY; Zhang, DM | 1 |
| Browne, AE; Chatterjee, K; Grossman, W; Karliner, JS; Lee, RJ; Parmley, WW; Sievers, RE; Zhu, BQ | 1 |
| Chocair, PR; de Paula, FJ; Ianhez, LE; Sabbaga, E | 1 |
| De Graeff, PA; De Langen, CD; Kingma, JH; Van Gilst, WH; Wesseling, H | 1 |
| Bussmann, WD; Hildenbrand, R; Klepzig, H; Micke, G | 1 |
| Gu, JK; Gu, YM; Jin, PY; Liu, ZY; Wu, WZ; Yang, YZ; Zhuang, WY; Zhuang, YC | 1 |
| Wang, JF; Xiao, WB | 1 |
| Bélichard, P; Cardinal, R; Gosselin, H; Nadeau, R; Paradis, P; Rouleau, JL; Savard, P | 1 |
| Pan, JY; Zhan, CY; Zhang, M; Zhu, XN | 1 |
| Filart, RA; Kowey, PR; Marinchak, RA; Rials, SJ; Wu, Y; Xu, X | 1 |
| Browne, AE; Chatterjee, K; Chou, TM; Lee, RJ; Parmley, WW; Pulukurthy, S; Sievers, RE; Sudhir, K; Sun, Y; Zhu, B | 1 |
| Hirakawa, S; Hirose, I; Ito, H; Nagata, K; Sahashi, T; Takai, K; Wada, H | 1 |
| Battisti, G; Calimici, R; Marrollo, E | 1 |
| Ribuot, C; Rochette, L | 1 |
| Belichard, P; Bril, A; Devissaguet, M; Ribuot, C; Rochette, L | 1 |
1 trial(s) available for captopril and Ventricular Fibrillation
| Article | Year |
|---|---|
Captopril in acute myocardial infarction: beneficial effects on infarct size and arrhythmias.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Enzyme Tests; Creatine Kinase; Double-Blind Method; Electrocardiography; Female; Hemodynamics; Humans; Isoenzymes; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Prospective Studies; Thrombolytic Therapy; Vasodilator Agents; Ventricular Fibrillation; Ventricular Premature Complexes | 1995 |
16 other study(ies) available for captopril and Ventricular Fibrillation
| Article | Year |
|---|---|
The potential mechanisms of reduced incidence of ventricular fibrillation as the presenting rhythm in sudden cardiac arrest.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Death, Sudden, Cardiac; Incidence; Propranolol; Rats; Rats, Sprague-Dawley; Time Factors; Ventricular Fibrillation | 2009 |
[Effects of ventricular arrhythmia during early ischemic myocardium with captopril].
Topics: Animals; Arrhythmias, Cardiac; Captopril; Disease Models, Animal; Electric Stimulation Therapy; Myocardial Ischemia; Rabbits; Ventricular Fibrillation | 2006 |
[Effects of Chinese herbal medicines Shengmai injection and Xuesaitong injection on ventricular fibrillation threshold and connexin 43 expression in rats with myocardial infarction].
Topics: Animals; Captopril; Connexin 43; Drug Combinations; Drugs, Chinese Herbal; Injections; Male; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Ventricular Fibrillation | 2011 |
Comparative effects of aspirin with ACE inhibitor or angiotensin receptor blocker on myocardial infarction and vascular function.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bleeding Time; Captopril; Disease Models, Animal; Endothelium, Vascular; Female; Hemodynamics; Losartan; Myocardial Infarction; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley; Refractory Period, Electrophysiological; Vasodilation; Ventricular Fibrillation | 2003 |
[Irreversible cardiogenic shock after captopril in a patient with refractory congestive cardiac insufficiency. Case report].
Topics: Adult; Captopril; Heart Failure; Humans; Hypotension; Male; Proline; Shock, Cardiogenic; Ventricular Fibrillation | 1983 |
Captopril reduces purine loss and reperfusion arrhythmias in the rat heart after coronary artery occlusion.
Topics: Animals; Captopril; Coronary Disease; Electrocardiography; Heart; Heart Rate; In Vitro Techniques; Male; Myocardial Contraction; Myocardium; Perfusion; Proline; Purines; Rats; Rats, Inbred Strains; Ventricular Fibrillation | 1984 |
Anti-arrhythmic effects of captopril on coronary occlusion and reperfusion periods in pigs.
Topics: Animals; Anti-Arrhythmia Agents; Captopril; Creatine Kinase; Isoenzymes; Myocardial Reperfusion Injury; Swine; Ventricular Fibrillation | 1993 |
Effects of lisinopril and captopril on calcium in rat heart.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium; Captopril; Cells, Cultured; Female; Lisinopril; Male; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase; Ventricular Fibrillation | 1993 |
Markedly different effects on ventricular remodeling result in a decrease in inducibility of ventricular arrhythmias.
Topics: Animals; Captopril; Cardiac Pacing, Artificial; Hypertrophy, Left Ventricular; Male; Myocardial Infarction; Propranolol; Rats; Rats, Wistar; Tachycardia, Ventricular; Ventricular Fibrillation; Ventricular Function, Left | 1994 |
[Reduction of incidence of ischemia-reperfusion induced ventricular fibrillation by captopril].
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Catecholamines; Male; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley; Thromboxane B2; Ventricular Fibrillation | 1995 |
Regression of left ventricular hypertrophy with captopril restores normal ventricular action potential duration, dispersion of refractoriness, and vulnerability to inducible ventricular fibrillation.
Topics: Action Potentials; Animals; Captopril; Disease Models, Animal; Electrophysiology; Hypertrophy, Left Ventricular; Rabbits; Ventricular Fibrillation | 1997 |
Comparative effects of pretreatment with captopril and losartan on cardiovascular protection in a rat model of ischemia-reperfusion.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Captopril; Disease Models, Animal; Electrocardiography; Female; Heart Rate; Losartan; Myocardial Infarction; Myocardial Reperfusion Injury; Random Allocation; Rats; Rats, Sprague-Dawley; Renin; Treatment Outcome; Ventricular Fibrillation | 2000 |
Role of the kinin-kallikrein system in the vasodilator action of an angiotensin converting enzyme inhibitor (captopril) on the systemic resistance and capacitance vessels of dogs.
Topics: Angiotensin II; Animals; Blood Pressure; Blood Vessels; Captopril; Compliance; Dogs; Injections, Intravenous; Kallikreins; Kinins; Vascular Resistance; Vasodilation; Ventricular Fibrillation | 1991 |
[Collateral effects induced by therapy with diuretics (clinical case of ventricular fibrillation caused by hypokalemia].
Topics: Aged; Captopril; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypokalemia; Male; Ventricular Fibrillation | 1991 |
Converting enzyme inhibitors (captopril, enalapril, perindopril) prevent early-post infarction ventricular fibrillation in the anaesthetized rat.
Topics: Anesthesia; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enalapril; Indoles; Male; Myocardial Infarction; Perindopril; Rats; Rats, Inbred Strains; Ventricular Fibrillation | 1987 |
Protective effect of angiotensin converting enzyme inhibitors (CEI): captopril and perindopril on vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion in rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Coronary Circulation; Coronary Disease; Heart Rate; In Vitro Techniques; Indoles; Male; Norepinephrine; Perindopril; Rats; Ventricular Fibrillation | 1987 |